Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort.

CONCLUSION: Amongst AF patients with long term use (≥1 year) of mHealth technology for optimising stroke prevention, symptom control and comorbidity management, adherence/persistence was good and associated with a reduction in adverse clinical outcomes. PMID: 33067121 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33067121?dopt=Abstract

Source: European Journal of Internal Medicine - October 13, 2020 Category: Internal Medicine Authors: Guo Y, Guo J, Shi X, Yao Y, Sun Y, Xia Y, Yu B, Liu T, Chen Y, Lip GYH, mAF-App II Trial investigators Tags: Eur J Intern Med Source Type: research